Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition kdunleavy Fri, 03/18/2022 – 18:13 Source link
Pfizer CEO Bourla scored big raise in 2021—to $24M—as drugmaker played a leading pandemic role esagonowsky Fri, 03/18/2022 – 14:40 Source link
After Pfizer’s pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission kdunleavy Fri, 03/18/2022 – 11:16 Source link
ironSource Ltd. (IS) reported third-quarter results, with in-line earnings and revenues topping analyst expectations. IS, which is a business platform for the app economy, also raised its FY2021 guidance and provided a fourth-quarter outlook above analyst expectations. Q3 Revenue Beat, EPS In-Line The company’s revenues jumped 60% year-over-year to $140.4 million, exceeding consensus estimates of $129.37 […]
Oracle (ORCL) has extended its partnership with India’s premier communications solutions provider, Bharti Airtel, to offer a wide range of cloud solutions to over 1 million enterprise customers in India. The partnership will aid India in its digital transformation endeavors. Shares of the multinational computer technology company have gained 64% over the past year. (See Oracle […]
Further, emerging markets could be a key driver of global economic growth over the next few decades and may offer compelling long-term growth prospects for Canadian investors. Investors who want to capitalize on powerful consumer trends within key markets, particularly Asia, that may be overlooked by index-based emerging markets strategies, could consider the recently launched […]
Shares of CAE (CAE) plunged 10% Thursday despite the company reporting a big jump in revenue and profit in the third quarter of 2021. The world leader in aviation training missed expectations as pilots’ use of its signature flight simulator plummeted. (See Insiders’ Hot Stocks on TipRanks) Revenue & Earnings Revenue came in at C$814.9 million in […]
Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition kdunleavy Fri, 03/18/2022 – 18:13 Source link
Pfizer CEO Bourla scored big raise in 2021—to $24M—as drugmaker played a leading pandemic role esagonowsky Fri, 03/18/2022 – 14:40 Source link
After Pfizer’s pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission kdunleavy Fri, 03/18/2022 – 11:16 Source link
Pfizer’s deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid kdunleavy Fri, 03/18/2022 – 09:33 Source link
El Salvadaor bought 410 bitcoin for $15 million Friday, the country’s President Nayib Bukele said on Twitter. “Some guys are selling really cheap,” he added in his tweet. Bitcoin was down about 12% late Friday to the $36,500 level as broader crypto prices also retreated. Nope, I was wrong, didn’t miss it. El Salvador just […]
Finally, the gang unpacked Buterin’s baby pod idea, which he floated as a means of female empowerment:“Disparities in economic success between men and women are far larger once marriage+children enter the picture. Synthetic wombs would remove the high burden of pregnancy, significantly reducing the inequality,” he wrote on Twitter. Source link
Don’t write off Ethereum just yet. The second-largest blockchain network by market capitalization after Bitcoin has become the dominant venue for some of the hottest cryptocurrency innovations, from decentralized finance (DeFi) to non-fungible tokens (NFT). The network’s popularity – and the high fees of transacting on it – has inspired a bevy of competitors aiming […]
The crypto market was in a sea of red on Friday as bitcoin, the world’s largest cryptocurrency by market capitalization, tumbled more than 10% over the past 24 hours. It appears that global investors have entered the year with a reduced appetite for risk, and so the correlations between speculative assets such as cryptocurrencies and […]
Led by the team from DelFresco Pure, this cannabis company boasts an illustrious track-record of growing and distributing. Check out the pre-IPO opportunity before Greenway goes public.
$0.10 per share
Publicly traded on the TSX.V, Fire & Flower is a growth-oriented cannabis company engaged in the production and sale of medical cannabis. Learn more about Fire & Flower here.
$0.10 per share
This cannabis company focuses on health and wellness products for medicinal and recreational use. Learn more about Harvest One to see if they’re the missing piece to your portfolio.
$0.10 per share